Cargando…

An Ensemble Matrix Completion Model for Predicting Potential Drugs Against SARS-CoV-2

Because of the catastrophic outbreak of global coronavirus disease 2019 (COVID-19) and its strong infectivity and possible persistence, computational repurposing of existing approved drugs will be a promising strategy that facilitates rapid clinical treatment decisions and provides reasonable justif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wen, Wang, Shulin, Xu, Junlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334363/ https://www.ncbi.nlm.nih.gov/pubmed/34367094 http://dx.doi.org/10.3389/fmicb.2021.694534

Ejemplares similares

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021)

Potential of Bacillus subtilis Against SARS-CoV-2 – A Sustainable Drug Development Perspective
por: Khodavirdipour, Amir, et al.
Publicado: (2022)

Drug repositioning for SARS-CoV-2 by Gaussian kernel similarity bilinear matrix factorization
por: Wang, Yibai, et al.
Publicado: (2022)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures
por: Peng, Lihong, et al.
Publicado: (2021)

The Potential Intermediate Hosts for SARS-CoV-2
por: Zhao, Jie, et al.
Publicado: (2020)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

Phytochemicals against SARS-CoV as potential drug leads
por: Swain, Shasank Sekhar, et al.
Publicado: (2021)

The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis
por: Fu, Yu, et al.
Publicado: (2021)

SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs
por: Min, Yuan-Qin, et al.
Publicado: (2020)

Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies
por: Kulandaisamy, Rajkumar, et al.
Publicado: (2022)

ABO Blood Group Incompatibility Protects Against SARS-CoV-2 Transmission
por: Boukhari, Rachida, et al.
Publicado: (2022)

What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
por: Martinez, Miguel Angel
Publicado: (2022)

An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2
por: Thapa, Himadri B., et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

SARS-CoV-2 and gastrointestinal diseases
por: Sha, Ailong, et al.
Publicado: (2023)

Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection
por: He, Li-Hong, et al.
Publicado: (2020)

Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
por: Zhang, Haiying, et al.
Publicado: (2022)

Respiratory Microbial Co-infection With SARS-CoV-2
por: Massey, Bill W., et al.
Publicado: (2020)

Characterization of host substrates of SARS-CoV-2 main protease
por: Melano, Ivonne, et al.
Publicado: (2023)

Prediction models for neutralization activity against emerging SARS-CoV-2 variants: A cross-sectional study
por: Goto, Atsushi, et al.
Publicado: (2023)

Evaluation of the presence of SARS-CoV-2 in vaginal and anal swabs of women with omicron variants of SARS-CoV-2 infection
por: Liu, Ding, et al.
Publicado: (2022)

Replication, pathogenicity, and transmission of SARS-CoV-2 in minks
por: Shuai, Lei, et al.
Publicado: (2020)

Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
por: Diesendorf, Viktoria, et al.
Publicado: (2023)

Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review
por: Jeong, Gi Uk, et al.
Publicado: (2020)

Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
por: Li, Tingting, et al.
Publicado: (2022)

On the origin and continuing evolution of SARS-CoV-2
por: Tang, Xiaolu, et al.
Publicado: (2020)

Recent progress in the development of potential drugs against SARS-CoV-2
por: Chen, Jianmin, et al.
Publicado: (2021)

In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles
por: Bartas, Martin, et al.
Publicado: (2020)

Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets
por: Bukhari, Syed Nisar Hussain, et al.
Publicado: (2021)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Hold Breath: Autonomic Neural Regulation of Innate Immunity to Defend Against SARS-CoV-2 Infection
por: Wang, Changle, et al.
Publicado: (2022)

Allosteric Regulation of 3CL Protease of SARS-CoV-2 and SARS-CoV Observed in the Crystal Structure Ensemble
por: Kidera, Akinori, et al.
Publicado: (2021)

Geographic and Genomic Distribution of SARS-CoV-2 Mutations
por: Mercatelli, Daniele, et al.
Publicado: (2020)

Mink, SARS-CoV-2, and the Human-Animal Interface
por: Fenollar, Florence, et al.
Publicado: (2021)

SARS-CoV-2 and Its Variants: The Pandemic of Unvaccinated
por: Angius, Fabrizio, et al.
Publicado: (2021)

Mapping Genetic Events of SARS-CoV-2 Variants
por: Qin, Luyao, et al.
Publicado: (2022)

A deep learning ensemble approach to prioritize antiviral drugs against novel coronavirus SARS-CoV-2 for COVID-19 drug repurposing
por: K., Deepthi, et al.
Publicado: (2021)

Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
por: Hentzien, Maxime, et al.
Publicado: (2022)

Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection
por: Bao, Lirong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ckg46etsp1kb4s32lc9i7ohi85